Matthieu Vermersch founded Singapore-based VisVires New Protein in 2014. See sector focus and contact routes.
Matthieu Vermersch founded Singapore-based VisVires New Protein in 2014, establishing Asia’s first venture fund dedicated exclusively to disruptive solutions for global food and feed systems, and he serves as its Founder and Managing Director with over 25 years of prior investment management experience including roles at Everest Capital and Banque Paribas. The firm invests without geographical boundaries to address unmet food system challenges, operating two funds with offices in Singapore and London while targeting sectors centered on new protein and sustainable food technologies. VisVires New Protein’s portfolio includes 10 companies such as Ÿnsect in France, In Ovo in the Netherlands, Aleph Farms in Israel, and Mushlabs in Germany, reflecting a global approach to sourcing impactful ventures. While specific check sizes and lead/follow behavior are not publicly detailed in available sources, the firm’s evolution into two funds suggests a capacity for meaningful capital deployment across stages. In 2024, VisVires New Protein rebranded to Clay Capital and raised $145 million, with Vermersch continuing as co-founder of the renamed entity. No distinctive public writing
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Singapore.
Investors like Matthieu Vermersch · Full investor directory · Investor access · Company funding database